Literature DB >> 20501323

Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion.

Mei Lin Tan1, Peter F M Choong, Crispin R Dass.   

Abstract

Chondrosarcoma develops as a result of overgrowth of chondrocytes and overproduction of cartilage matrix. It is currently surgically treated, although non-invasive methods are being sought. In this report, pigment epithelium-derived factor (PEDF) induced apoptosis in the chondrosarcoma cell line - JJ012, with upregulation of Bax, Fas, caspase-3 and -6 and downregulation of Bcl-2. Cell cycling was also decreased with decreased expression of p38, p-Akt, p-Erk and JNK1 and increased expression of p73 and E2F1. Furthermore, PEDF increased adhesion of cells to collagen-I, with decreased expression of p-Fak, RhoA and cdc42. Invasion of cells through collagen-I was also reduced by PEDF, with decreased expression of uPAR, MMP-14 and increased expression of PAI-1. These findings seminally indicate that PEDF may have potential as an anti-cancer agent against chondrosarcoma. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501323     DOI: 10.1016/j.bbrc.2010.05.098

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Potential of Protein-based Anti-metastatic Therapy with Serpins and Inter α-Trypsin Inhibitors.

Authors:  Ulrich H Weidle; Fabian Birzele; Georg Tiefenthaler
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 4.069

Review 2.  The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential.

Authors:  S Patricia Becerra; Vicente Notario
Journal:  Nat Rev Cancer       Date:  2013-03-14       Impact factor: 60.716

3.  Pigment epithelium derived factor inhibits the growth of human endometrial implants in nude mice and of ovarian endometriotic stromal cells in vitro.

Authors:  Yanmei Sun; Xuan Che; Libo Zhu; Mengdan Zhao; Guofang Fu; Xiufeng Huang; Hong Xu; Fuqiang Hu; Xinmei Zhang
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

4.  Mutations in SERPINF1 cause osteogenesis imperfecta type VI.

Authors:  Erica P Homan; Frank Rauch; Ingo Grafe; Caressa Lietman; Jennifer A Doll; Brian Dawson; Terry Bertin; Dobrawa Napierala; Roy Morello; Richard Gibbs; Lisa White; Rika Miki; Daniel H Cohn; Susan Crawford; Rose Travers; Francis H Glorieux; Brendan Lee
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

Review 5.  Cell and molecular biology underpinning the effects of PEDF on cancers in general and osteosarcoma in particular.

Authors:  Vijay Chandolu; Crispin R Dass
Journal:  J Biomed Biotechnol       Date:  2012-05-28

6.  rAAV Vectors as Safe and Efficient Tools for the Stable Delivery of Genes to Primary Human Chondrosarcoma Cells In Vitro and In Situ.

Authors:  Henning Madry; Jagadeesh K Venkatesan; Gertrud Schmitt; Sarah Schetting; Myriam Ekici; Dieter Kohn; Magali Cucchiarini
Journal:  Sarcoma       Date:  2012-05-07

7.  The Transient Chondrocyte Phenotype in Human Osteophytic Cartilage: A Role of Pigment Epithelium-Derived Factor?

Authors:  Patricia Klinger; Christian Beyer; Arif B Ekici; Hans-Dieter Carl; Georg Schett; Bernd Swoboda; Friedrich F Hennig; Kolja Gelse
Journal:  Cartilage       Date:  2013-07       Impact factor: 4.634

8.  PEDF Is Associated with the Termination of Chondrocyte Phenotype and Catabolism of Cartilage Tissue.

Authors:  P Klinger; S Lukassen; F Ferrazzi; A B Ekici; T Hotfiel; B Swoboda; T Aigner; K Gelse
Journal:  Biomed Res Int       Date:  2017-01-16       Impact factor: 3.411

Review 9.  Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review.

Authors:  Louiza Belkacemi; Shaun Xiaoliu Zhang
Journal:  J Exp Clin Cancer Res       Date:  2016-01-08

10.  Impact of pigment epithelium-derived factor on colorectal cancer in vitro and in vivo.

Authors:  Rhiannon L Harries; Sioned Owen; Fiona Ruge; Meleri Morgan; Jun Li; Zhangtao Zhang; Keith G Harding; Jared Torkington; Wen G Jiang; Jun Cai
Journal:  Oncotarget       Date:  2018-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.